Dr. Matthew Ross Livingood, MD

Dr. Livingood practices at Arlington Dermatology in Arlington, Virginia.

Dr. Livingood's NPI, 1770926255, was assigned on April 15, 2013. Dr. Livingood graduated from Georgetown University School of Medicine in 2013. Dr. Livingood holds Virginia license 0101262483.

Dr. Livingood's primary practice is Arlington Dermatology, at 4249 25th N St, Arlington, VA 22207 in Arlington County. The practice phone is (301) 908-8609.

Dr. Livingood's primary practice is Arlington Dermatology in Arlington, Virginia. The medical group on file is Arlington Dermatology. Dmand AI also links Dr. Livingood to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Livingood practices. Vendor and product names are available with a free account.

Dermatology is Dr. Livingood's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Livingood's licenses on file in 2 states: Virginia and District of Columbia.

CMS data shows 1,090 Medicare services from Dr. Livingood across 12 procedure codes in 2024, for 205 Medicare patients. Medicare paid $50,510 for them. Every service was in an office.

CMS counts 205 Medicare patients who saw Dr. Livingood in 2024. The largest group is 65 to 74, with 110 patients. 69% of them have high cholesterol, and 54% have high blood pressure. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Livingood's median patient age at 41, with 40% women.

In 2024, Dr. Livingood wrote 214 Medicare Part D claims for 94 patients. 89% of them were for generic drugs. CMS names the drug for 106 of them, across 6 drugs with 11 or more claims each, at $1,941 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

Dr. Livingood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 347 procedures of removal of skin lesions by Dr. Livingood, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Livingood. Dr. Livingood's most frequent co-authors are Alan Stuart Boyd, MD, Jo-David Fine, MD and Shane A. Grace, MD.

CMS Open Payments shows 439 general payments to Dr. Livingood from 39 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,339.

Dr. Livingood graduated from Georgetown University School of Medicine in 2013.